This Graduate Certificate program offers advanced training in the preclinical stages of drug development, focusing on translational medicine and its associated research. Translational medicine, often described as the 'bench to bedside' process, aims to accelerate the movement of scientific discoveries from the laboratory into clinical practice for patient diagnosis and treatment. The program delves into the scientific, regulatory, ethical, and societal challenges inherent in this progression. Students will gain foundational knowledge in preclinical drug development, translational research methodologies, and regulatory controls. The curriculum emphasizes the multidisciplinary nature of enhancing disease research and drug development, exploring the intricate connections between science, medicine, regulatory affairs, ethics, and societal impact. This accredited program is designed to cultivate specialists in high-demand areas within regulatory and quality science.
Graduates of this program are prepared for a wide range of career opportunities within the pharmaceutical and regulatory sectors, mirroring the diverse roles available within organizations like the FDA and the broader industry. The skills acquired are applicable across various disciplines.
All courses offered by the Department of Regulatory and Quality Sciences can be taken online or in-person. The program is structured for working professionals, allowing them to take one or two courses per term.
Tuition and living costs are not specified on the provided pages.
The program is an accredited graduate certificate.
This program offers advanced training in the preclinical stages of drug development, focusing on translational medicine. It covers the scientific, regulatory, ethical, and societal challenges involved in moving research from the lab to clinical practice.
A Bachelor's degree is required for admission to the program. Specific details on other prerequisites are not provided, and applicants are encouraged to request more information.
The Graduate Certificate in Preclinical Drug Development requires the completion of 12 units. The program is designed for working professionals and can be completed flexibly, with options for one or two courses per term.
Tuition and living costs are not specified on the provided pages. Applicants are instructed to inquire for current tuition rates and estimated living costs.
To apply, you should first request information, review the admissions requirements, and then submit your online application. The application deadline is June 6th, with the program starting on August 24th.
Graduates are prepared for roles in pharmaceutical and regulatory sectors, including research and development, clinical trials management, quality assurance, regulatory affairs, and project management.